Illumina signs MoU with PHASE to Advance Oncology Testing in the Greater Bay Area and Contribute to the ''Healthy China''
SHANGHAI,Nov. 8,2024-- Illumina Hong Kong LIMITED (Illumina),a global leader in DNA sequencing and array-based technologies,and PHASE Scientific International Limited (PHASE),a Hong Kong-based biotec